Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayant Talwalkar

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2009
Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-upEinar Björnsson, Evangelos Kalaitzakis, Matthias Neuhauser, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 25, 2011
Portal hypertension correlates with splenic stiffness as measured with MR elastographyGeir I Nedredal, Meng Yin, Travis McKenzie, et al.
Gastroenterology|November 5, 2003
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States communityKiran Bambha, W Ray Kim, Jayant Talwalkar, et al.
Gastroenterology|March 11, 2015
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective StudyNaga Chalasani, Herbert L Bonkovsky, Robert Fontana, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 21, 2009
A prospective pilot study of circulating endothelial cells as a potential new biomarker in portal hypertensionSoha S Abdelmoneim, Jayant Talwalkar, Saurabh Sethi, et al.
Journal of the National Cancer Institute|May 15, 2008
Design and endpoints of clinical trials in hepatocellular carcinomaJosep M Llovet, Adrian M Di Bisceglie, Jordi Bruix, et al.
Transplantation|March 9, 2017
Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing CholangitisMohamad A Mouchli, Siddharth Singh, Edward V Loftus, et al.
Journal of Clinical and Experimental Hepatology|March 11, 2015
Comparison of circulating endothelial cell/platelet count ratio to aspartate transaminase/platelet ratio index for identifying patients with cirrhosisSaurabh Sethi, Douglas A Simonetto, Soha S Abdelmoneim, et al.
Hepatology (Baltimore, Md.)|July 22, 2014
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury NetworkVictor J Navarro, Huiman Barnhart, Herbert L Bonkovsky, et al.
Journal of the American Medical Informatics Association : JAMIA|July 11, 2013
A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injuryCasey Lynnette Overby, Jyotishman Pathak, Omri Gottesman, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2009
Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-upEinar Björnsson, Evangelos Kalaitzakis, Matthias Neuhauser, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 25, 2011
Portal hypertension correlates with splenic stiffness as measured with MR elastographyGeir I Nedredal, Meng Yin, Travis McKenzie, et al.
Gastroenterology|November 5, 2003
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States communityKiran Bambha, W Ray Kim, Jayant Talwalkar, et al.
Gastroenterology|March 11, 2015
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective StudyNaga Chalasani, Herbert L Bonkovsky, Robert Fontana, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 21, 2009
A prospective pilot study of circulating endothelial cells as a potential new biomarker in portal hypertensionSoha S Abdelmoneim, Jayant Talwalkar, Saurabh Sethi, et al.
Journal of the National Cancer Institute|May 15, 2008
Design and endpoints of clinical trials in hepatocellular carcinomaJosep M Llovet, Adrian M Di Bisceglie, Jordi Bruix, et al.
Transplantation|March 9, 2017
Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing CholangitisMohamad A Mouchli, Siddharth Singh, Edward V Loftus, et al.
Journal of Clinical and Experimental Hepatology|March 11, 2015
Comparison of circulating endothelial cell/platelet count ratio to aspartate transaminase/platelet ratio index for identifying patients with cirrhosisSaurabh Sethi, Douglas A Simonetto, Soha S Abdelmoneim, et al.
Hepatology (Baltimore, Md.)|July 22, 2014
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury NetworkVictor J Navarro, Huiman Barnhart, Herbert L Bonkovsky, et al.
Journal of the American Medical Informatics Association : JAMIA|July 11, 2013
A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injuryCasey Lynnette Overby, Jyotishman Pathak, Omri Gottesman, et al.
Pageof 3